Jiewen Qiu

437 total citations
25 papers, 334 citations indexed

About

Jiewen Qiu is a scholar working on Neurology, Molecular Biology and Neurology. According to data from OpenAlex, Jiewen Qiu has authored 25 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 9 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Jiewen Qiu's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Mitochondrial Function and Pathology (3 papers). Jiewen Qiu is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Mitochondrial Function and Pathology (3 papers). Jiewen Qiu collaborates with scholars based in China, United States and Japan. Jiewen Qiu's co-authors include Pingyi Xu, Wenyuan Guo, Yuwan Lin, Mingshu Mo, Jianmin Huang, Tian‐Hua Huang, Tiangang Zhuang, Xiaoqin Zhu, Miaomiao Zhou and Xin Ren and has published in prestigious journals such as ACS Applied Materials & Interfaces, Experimental Cell Research and European Journal of Pharmacology.

In The Last Decade

Jiewen Qiu

24 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiewen Qiu China 12 88 56 55 49 41 25 334
Xueqin Song China 12 274 3.1× 50 0.9× 85 1.5× 23 0.5× 22 0.5× 40 534
Hadi Abou‐El‐Hassan United States 13 244 2.8× 61 1.1× 55 1.0× 47 1.0× 43 1.0× 19 487
Marco Calabresi Italy 11 111 1.3× 76 1.4× 125 2.3× 22 0.4× 42 1.0× 18 467
David Heilman United States 10 263 3.0× 56 1.0× 34 0.6× 306 6.2× 66 1.6× 11 741
Wakana Mori Japan 11 160 1.8× 45 0.8× 14 0.3× 23 0.5× 33 0.8× 37 496
William R. Mancini United States 11 259 2.9× 49 0.9× 21 0.4× 44 0.9× 40 1.0× 18 522
Rao Kalla United States 13 248 2.8× 26 0.5× 25 0.5× 33 0.7× 21 0.5× 18 592
Saeideh Nozohouri United States 14 183 2.1× 41 0.7× 41 0.7× 101 2.1× 81 2.0× 25 422
M. Yano Japan 10 159 1.8× 44 0.8× 36 0.7× 9 0.2× 259 6.3× 14 516
Yoshinori TERAMURA Japan 7 208 2.4× 15 0.3× 28 0.5× 57 1.2× 26 0.6× 11 376

Countries citing papers authored by Jiewen Qiu

Since Specialization
Citations

This map shows the geographic impact of Jiewen Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiewen Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiewen Qiu more than expected).

Fields of papers citing papers by Jiewen Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiewen Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiewen Qiu. The network helps show where Jiewen Qiu may publish in the future.

Co-authorship network of co-authors of Jiewen Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiewen Qiu. A scholar is included among the top collaborators of Jiewen Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiewen Qiu. Jiewen Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yongkui, et al.. (2025). Non-circular Coherent Signal DOA Estimation Based on Block Diagonal Spatial Smoothing Mechanism. Circuits Systems and Signal Processing. 44(12). 9549–9569.
2.
He, Shuying, et al.. (2025). Ta4C3 MXene Slows Progression of Fatty Liver Disease through Its Anti-Inflammatory and ROS-Scavenging Effects. ACS Applied Materials & Interfaces. 17(11). 17217–17229. 4 indexed citations
3.
Lin, Yuwan, Miaomiao Zhou, Wenyuan Guo, et al.. (2023). Correlation of SV2C rs1423099 single nucleotide polymorphism with sporadic Parkinson's disease in Han population in Southern China. Neuroscience Letters. 813. 137426–137426. 3 indexed citations
4.
Qiu, Jiewen, et al.. (2023). Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson’s Disease. Brain Sciences. 13(8). 1166–1166. 11 indexed citations
5.
Lin, Yuwan, Zhiling Zhang, Yuting Tang, et al.. (2023). CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in in vitro and in vivo models of Parkinson’s disease. Neural Regeneration Research. 19(1). 196–204. 3 indexed citations
6.
Qiu, Jiewen, Shiyin Li, Yunxin Wang, et al.. (2023). Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease. Frontiers in Aging Neuroscience. 14. 1077738–1077738. 8 indexed citations
7.
Zhou, Miaomiao, Yuwan Lin, Zhiling Zhang, et al.. (2023). The role of domain alterations in F1Fo-ATPase dysfunction associated to neurodegenerative diseases. 2–2. 3 indexed citations
8.
Tao, Kai, Mingshu Mo, Wenyuan Guo, et al.. (2022). Chaperone-mediated Autophagy Regulates Cell Growth by Targeting SMAD3 in Glioma. Neuroscience Bulletin. 38(6). 637–651. 5 indexed citations
9.
Zhang, Wenlong, Yuwan Lin, Jiewen Qiu, et al.. (2021). A hydrogen sulfide donor suppresses pentylenetetrazol-induced seizures in rats via PKC signaling. European Journal of Pharmacology. 898. 173959–173959. 8 indexed citations
10.
Lin, Yuwan, Miaomiao Zhou, Wei Dai, et al.. (2021). Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease. Frontiers in Aging Neuroscience. 13. 634213–634213. 17 indexed citations
11.
Mo, Mingshu, Yuting Tang, Jiewen Qiu, et al.. (2021). Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease. Frontiers in Aging Neuroscience. 13. 753210–753210. 12 indexed citations
12.
Li, Peng, Zhe Li, Mingshu Mo, et al.. (2020). The outcome and burden of Chinese patients with neurodegenerative diseases: A 10‐year clinical feature study. International Journal of Clinical Practice. 74(9). e13534–e13534. 7 indexed citations
13.
Guo, Wenyuan, Miaomiao Zhou, Jiewen Qiu, et al.. (2019). Association of LAG3 genetic variation with an increased risk of PD in Chinese female population. Journal of Neuroinflammation. 16(1). 270–270. 33 indexed citations
14.
Chen, Xiang, Yousheng Xiao, Miaomiao Zhou, et al.. (2019). Genetic analysis of NUS1 in Chinese patients with Parkinson's disease. Neurobiology of Aging. 86. 202.e5–202.e6. 12 indexed citations
15.
Qiu, Jiewen, Miaomiao Zhou, Shuxuan Huang, et al.. (2019). Analysis of Cerebrospinal Fluid Soluble TREM2 and Polymorphisms in Sporadic Parkinson’s Disease in a Chinese Population. Journal of Molecular Neuroscience. 70(2). 294–301. 20 indexed citations
16.
Ren, Xin, Xinliang Mao, Luqin Si, et al.. (2008). Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration. European Journal of Pharmaceutics and Biopharmaceutics. 70(1). 279–288. 52 indexed citations
17.
Huang, Jun, James H. Liu, Peipei Jin, et al.. (2006). Development of permanent magnetic refrigerator at room temperature. Rare Metals. 25(6). 641–644. 14 indexed citations
18.
Yoon, Ji Won, Jiewen Qiu, Sheng Cai, et al.. (2006). The retinitis pigmentosa-mutated RP2 protein exhibits exonuclease activity and translocates to the nucleus in response to DNA damage. Experimental Cell Research. 312(8). 1323–1334. 21 indexed citations
19.
Chen, Ming‐Chun, et al.. (2004). [Studies on mother-to-infant transmission of hepatitis C virus (HCV) and hepatitis G virus (HGV) co-infection].. PubMed. 39(7). 439–41. 1 indexed citations
20.
Huang, Jianmin, et al.. (2002). Studies on the integration of hepatitis B virus DNA sequence in human sperm chromosomes.. PubMed. 4(3). 209–12. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026